60 / 100

Dr. Kazutaka Ohi, Psychiatry, Best Researcher Award

Doctorate at Gifu University Graduate School of Medicine, Japan

Summary:

Dr. Kazutaka Ohi is an Associate Professor in the Department of Psychiatry at Gifu University Graduate School of Medicine, Japan. He received his Medical Degree from Kanazawa Medical University in 2005 and completed his Ph.D. in Psychiatry at Osaka University Graduate School of Medicine in 2011. Dr. Ohi’s research interests include genetics for psychiatric disorders, imaging genetics, neurocognitive genetics, personality traits, and RNA-sequencing. He has received numerous awards for his contributions to psychiatry and neuroscience, including the Young Psychiatrist Award and Young Investigator Award for Best Poster at international congresses. Dr. Ohi’s work aims to unravel the genetic and neurobiological mechanisms underlying psychiatric disorders to inform more effective treatments and interventions.

Professional Profile:

šŸ‘©ā€šŸŽ“Education:

Medical Degree (M.D.):

  • Dr. Ohi attended Kanazawa Medical University in Ishikawa, Japan, where he completed his medical education.
  • He obtained his Medical Degree (M.D.) in 2005.

Ph.D. in Psychiatry:

  • Following his medical studies, Dr. Ohi pursued further academic training in psychiatry.
  • He joined the Ph.D. program in the Department of Psychiatry at Osaka University Graduate School of Medicine in Osaka, Japan.
  • Dr. Ohi successfully defended his doctoral dissertation and was awarded a Ph.D. degree in 2011.

Professional Experience:

Dr. Kazutaka Ohi has garnered a wealth of professional experience in psychiatry and neuroscience through his roles at esteemed institutions. Here is a summary of his professional journey:

Dr. Ohi’s career began with clinical training at Osaka University Hospital in Osaka, Japan, from 2005 to 2007. Subsequently, he worked at the National Hospital Organization’s Yamato Mental-Medical Center in Nara, Japan, from 2011 to 2014, where he further honed his clinical skills and research interests.

In 2014, Dr. Ohi embarked on a significant academic endeavor by undertaking a postdoctoral fellowship at the Lieber Institute for Brain Development, located at the Johns Hopkins Medical Campus in Maryland, USA. This experience provided him with exposure to cutting-edge research methodologies and collaborations in the field of psychiatry and neuroscience.

Following his postdoctoral fellowship, Dr. Ohi held faculty positions at Kanazawa Medical University in Ishikawa, Japan. He served as an Assistant Professor in the Department of Neuropsychiatry from 2015 to 2016 and was later promoted to Associate Professor, a position he held until 2019.

Currently, Dr. Ohi holds the position of Associate Professor in the Department of Psychiatry at Gifu University Graduate School of Medicine in Gifu, Japan. In this role, he continues to contribute significantly to research, teaching, and clinical practice in the field of psychiatry, with a focus on genetics for psychiatric disorders, imaging genetics, neurocognitive genetics, and RNA-sequencing.

Throughout his professional journey, Dr. Ohi has demonstrated a strong commitment to advancing the understanding and treatment of psychiatric disorders through his research, clinical practice, and academic leadership. His contributions have earned him recognition and respect within the global scientific community.

Research Interest:

Genetics for Psychiatric Disorders:

  • Dr. Ohi is interested in understanding the genetic underpinnings of psychiatric disorders such as schizophrenia, bipolar disorder, major depressive disorder, and anxiety disorders.
  • His research focuses on identifying genetic risk factors, exploring gene-environment interactions, and elucidating the molecular mechanisms involved in these disorders.

Imaging Genetics:

  • Dr. Ohi investigates the relationship between genetic variation and brain imaging phenotypes.
  • He utilizes advanced neuroimaging techniques such as voxel-based morphometry (VBM) analysis to examine structural brain differences associated with genetic factors implicated in psychiatric disorders.

Neurocognitive Genetics:

  • Dr. Ohi’s research explores the genetic basis of neurocognitive functioning, including cognitive impairments observed in psychiatric disorders.
  • He investigates how genetic variation influences cognitive domains such as memory, attention, executive function, and social cognition, and their relevance to psychiatric symptomatology.

Personality Traits:

  • Dr. Ohi studies the genetic basis of personality traits and their association with psychiatric disorders.
  • He investigates how genetic factors contribute to individual differences in personality dimensions such as extraversion, neuroticism, conscientiousness, agreeableness, and openness to experience, and their impact on mental health outcomes.

RNA-Sequencing:

  • Dr. Ohi employs RNA-sequencing techniques to examine gene expression profiles and molecular pathways relevant to psychiatric disorders.
  • He investigates transcriptomic changes in brain tissue and peripheral samples to identify novel biomarkers, therapeutic targets, and pathways dysregulated in psychiatric conditions.

Award and Honors:

Young Psychiatrist Award, 1st AsCNP-ASEAN International Congress of Neuropsychopharmacology (2019):

    • Dr. Ohi was honored with the Young Psychiatrist Award at the 1st AsCNP-ASEAN International Congress of Neuropsychopharmacology in recognition of his significant contributions to the field.

Young Investigator Award for Best Poster, 13th World Congress of Biological Psychiatry (2017):

    • At the 13th World Congress of Biological Psychiatry, Dr. Ohi received the Young Investigator Award for presenting the best poster, acknowledging the excellence and impact of his research.

Young Psychiatrist Award, 5th Congress of Asian College of Neuropsychopharmacology (AsCNP) (2017):

    • Dr. Ohi was recognized with the Young Psychiatrist Award at the 5th Congress of the Asian College of Neuropsychopharmacology for his significant contributions to the field of neuropsychopharmacology.

Young Psychiatrist Award, WPA International Congress (2015):

    • Dr. Ohi was honored with the Young Psychiatrist Award at the WPA International Congress, reflecting his outstanding achievements and dedication to the field of psychiatry.

Young Scientists Award, 11th World Congress of Biological Psychiatry (2013):

    • At the 11th World Congress of Biological Psychiatry, Dr. Ohi received the Young Scientists Award in recognition of his promising research contributions and potential impact on the field.

Rafaelsen Young Investigator Award, 28th CINP World Congress of Neuropsychopharmacology (2012):

    • Dr. Ohi was honored with the Rafaelsen Young Investigator Award at the 28th CINP World Congress of Neuropsychopharmacology, highlighting his exceptional research accomplishments and potential as a young investigator.

Young Investigator Fellowship Award, 2nd Congress of Asian College of Neuropsychopharmacology (2011):

    • At the 2nd Congress of the Asian College of Neuropsychopharmacology, Dr. Ohi was recognized with the Young Investigator Fellowship Award for his promising research contributions to the field.

Young Investigator Award for Best Poster, 10th World Congress of Biological Psychiatry (2011):

    • Dr. Ohi received the Young Investigator Award for presenting the best poster at the 10th World Congress of Biological Psychiatry, acknowledging the excellence and impact of his research.

Publications Top Noted:Ā 

Genetic influences on schizophrenia and subcortical brain volumes: large-scale proof of concept

  • Authors: B Franke, JL Stein, S Ripke, V Anttila, DP Hibar, KJE Van Hulzen, and others
  • Published in: Nature Neuroscience, Volume 19, Issue 3, Pages 420-431, Year 2016

White matter microstructural alterations across four major psychiatric disorders: mega-analysis study in 2937 individuals

  • Authors: D Koshiyama, M Fukunaga, N Okada, K Morita, K Nemoto, K Usui, and others
  • Published in: Molecular Psychiatry, Volume 25, Issue 4, Pages 883-895, Year 2020

A human-specific AS3MT isoform and BORCS7 are molecular risk factors in the 10q24.32 schizophrenia-associated locus

  • Authors: M Li, AE Jaffe, RE Straub, R Tao, JH Shin, Y Wang, Q Chen, C Li, Y Jia, and others
  • Published in: Nature Medicine, Volume 22, Issue 6, Pages 649-656, Year 2016

Sensory cognitive abnormalities of pain in autism spectrum disorder: a caseā€“control study

  • Authors: Y Yasuda, R Hashimoto, A Nakae, H Kang, K Ohi, H Yamamori, and others
  • Published in: Annals of General Psychiatry, Volume 15, Pages 1-8, Year 2016

Meta-analyses of Blood Homocysteine Levels for Gender and Genetic Association Studies of the MTHFR C677T Polymorphism in Schizophrenia

  • Authors: A Nishi, S Numata, A Tajima, M Kinoshita, K Kikuchi, S Shimodera, and others
  • Published in: Schizophrenia Bulletin, Volume 40, Issue 5, Pages 1154-1163, Year 2014

 

Kazutaka Ohi | Psychiatry | Best Researcher Award

You May Also Like